| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |